Back to Archived Journals » Core Evidence » Volume 14

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy

Total article views   HTML views PDF downloads Totals
16,830 Dovepress* 9,624+ 1,548 11,172
PubMed Central* 7,206 750 7,956
Totals 16,830 2,298 19,128
*Since 26 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar